Condition

Congenital Afibrinogenemia (2)

Hypofibrinogenemia (1)

Overall Status

Completed (1)

Suspended (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 3 (1)

Sponsor

Grifols Therapeutics LLC (1)

Instituto Grifols, S.A. (1)

Collaborator

Instituto Grifols, S.A. (1)

Intervention

fib grifols (1)

human plasma-derived fibrinogen concentrate (1)

Study Documents

Intervention Type

biological (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

congenital afibrinogenemia

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Congenital Afibrinogenemia Trial in Worldwide (Human Plasma-Derived Fibrinogen Concentrate)

Completed

Congenital Afibrinogenemia

Human Plasma-Derived Fibrinogen Concentrate

New Hyde Park, New York
+5 more

Mar 22, 2022

Congenital Afibrinogenemia, Hypofibrinogenemia Trial in Worldwide (FIB Grifols)

Suspended

Congenital Afibrinogenemia
Hypofibrinogenemia

FIB Grifols

New Hyde Park, New York
+9 more

May 11, 2021